research: denosumab for treatment of bone mets in MBC

Scientists studying the protein RANKL and its role in the production of bone cells have discovered a connection with breast cancer. RANKL is a protein that activates bone cells to replace lost bone, e.g. through osteoporosis. Normal RANKL activity includes stimulation of bone cells to die and replacement cells to grow. When something disrupts the RANKL system, the protein overproduces, causing bone cell production but interrupting cellular death.

The connection to breast cancer is that scientists have found the same protein in the tissue of breast cancer. Further, synthetic hormones (progestin) found in HRT and contraceptives cause RANKL production, which in turn causes breast cancer cells to multiply and to fail to die.

A proposal is pending for research that would study denosumab, a monoclonal antibody that blocks RANKL for treating bone metastasis in advanced breast cancer. Another study of denosumab treatment for osteoporosis has already received approval in the US and the EU.

Institute of Molecular Biotechnology. “How HRT and the Pill Can Lead to Breast Cancer: New Research Suggests Possible Treatment.” ScienceDaily 10/1/10.

Daniel Schramek, Andreas Leibbrandt, Verena Sigl, Lukas Kenner, John A. Pospisilik, Heather J. Lee, Reiko Hanada, Purna A. Joshi, Antonios Aliprantis, Laurie Glimcher, Manolis Pasparakis, Rama Khokha, Christopher J. Ormandy, Martin Widschwendter, Georg Schett, Josef M. Penninger. “Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer.” Nature, 2010; DOI: 10.1038/nature09387.

5 6 7 8
© 2004-2010 Donna Peach. All rights reserved.
Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s